Epitalon peptide dose ranges in published research typically run 5–10 mg per day for 10–20 days. Learn about protocols, routes, and human safety.
There is no universally accepted epitalon peptide dose for humans because epitalon is not FDA-approved for human use in the United States. Published research protocols most often describe 5 to 10 mg per day given subcutaneously for 10 to 20 days, sometimes repeated once or twice per year. Those numbers come from small studies, and they should not be treated as established medical guidance.
What Is Epitalon and Why Dose Matters
Search results for what is epitalon peptide typically describe it as a synthetic tetrapeptide made of four amino acids: alanine, glutamic acid, aspartic acid, and glycine. It was developed by Russian scientist Vladimir Khavinson and is also spelled epithalon or epithalamin. The compound is studied mainly for its effects on telomerase, the pineal gland, and circadian rhythms.
Dose matters because epitalon is a research chemical, not a standardized drug. Different studies use different amounts, routes, and cycle lengths. A dose that appears in a rodent study cannot be directly converted into a human protocol.
Typical Epitalon Dose Ranges Reported in Research
The table below summarizes dose ranges that appear most often in published literature. These are research numbers, not recommendations.
| Protocol type | Typical epitalon dose | Duration | Route |
|---|---|---|---|
| Russian clinical studies | 5–10 mg per day | 10–20 days | Subcutaneous injection |
| Longevity research protocols | 5–10 mg per day | 10–20 days, 1–2 cycles per year | Subcutaneous injection |
| Rodent studies | 0.1–1 mg per kg per day | 5–20 days | Subcutaneous or intranasal |
| Cell culture experiments | 10⁻⁷ to 10⁻⁵ M | Hours to days | Cell medium |
Most human-adjacent research uses 5 mg or 10 mg per injection. Some protocols split the dose into two daily injections, while others use a single daily dose in the evening. No head-to-head trial has compared these schedules.
Route of Administration Changes the Dose
Subcutaneous injection is the route used in nearly all clinical research on epitalon. Intranasal sprays appear in some Russian studies, but absorption is less predictable than injection. Oral capsules are widely sold online, but peptides are generally broken down in the digestive tract, so oral bioavailability is poor.
Because route changes absorption, you cannot compare a 5 mg injection to a 5 mg capsule or nasal spray. The same milligram amount may produce very different blood levels.
Epitalon Dose Protocol: Cycling and Timing
A typical epitalon dose protocol in the literature runs for 10 to 20 consecutive days, followed by a long break. Some researchers repeat the cycle every six months; others use it once per year. The rationale is that telomerase activity and pineal function may respond to short pulses rather than continuous exposure.
Timing also varies. Some protocols inject in the morning, while others use the evening to mimic natural melatonin rhythms. There is no clear evidence that one time of day is superior.
Common cycle patterns include:
- Short cycle: 5–10 mg daily for 10 days.
- Standard research cycle: 5–10 mg daily for 20 days.
- Split dose: 2.5–5 mg twice daily for 10–20 days.
- Repeated cycle: One 10–20 day cycle every 6 months.
These patterns are drawn from small studies and anecdotal reports. They are not validated by large randomized trials.
Benefits of Epitalon Peptide: What the Evidence Actually Shows
When people discuss the benefits of epitalon peptide, they usually point to telomerase activation, improved sleep quality, and antioxidant effects. Cell studies show that epitalon can increase telomerase activity in human fibroblasts. Animal studies suggest it may regulate melatonin and normalize circadian rhythms.
Human data remain limited. Most clinical research comes from a small number of Russian studies with modest sample sizes. Those studies report improvements in melatonin levels, immune markers, and some age-related parameters, but they have not been replicated on a large scale in Western populations.
Epitalon is not a proven anti-aging cure. People searching for what does epitalon peptide do in the body will find mostly cell and animal studies, not large human trials.
Safety, Legal Status, and Measuring Doses
Epitalon is sold as a research chemical and is not approved by the FDA for human use. It is not a dietary supplement, and products labeled as such may be misbranded. Injecting any research peptide carries risks of infection, allergic reaction, and dosing errors.
If you handle epitalon powder in a laboratory setting, a peptide calculator dose tool can help convert milligrams to micrograms per unit on a syringe. Always double-check your math and use sterile technique.
Talk to a licensed healthcare professional before using any research peptide. This article is for informational purposes only and does not constitute medical advice.
Frequently Asked Questions
What is the typical epitalon peptide dose used in studies?
Published research protocols most commonly use 5 to 10 mg per day, given subcutaneously for 10 to 20 days. Animal studies use much smaller weight-based doses, but those cannot be directly converted to humans. There is no FDA-approved human dose.
How often should epitalon be cycled?
Most research protocols use one 10- to 20-day cycle, then a break of several months. Some protocols repeat the cycle once or twice per year. No large trial has compared different cycling schedules.
Is epitalon peptide legal to buy in the US?
Epitalon is sold as a research chemical, not as an FDA-approved drug or dietary supplement. Buying it for personal human use is not legal under FDA rules. Consult a healthcare professional before using any research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.